Plague Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Plague Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Therapeutic Area

Report Description

Plague is caused by Yersinia pestis, a zoonotic microorganism generally found in mammals and fleas. Individuals contaminated with Yersinia pestis frequently show symptoms after an incubation time of one to seven days. The three fundamental clinical types of plague diseases are bubonic, pneumonic, and septicemic. Bubonic plague is the most common type and is characterized by swollen lymph hubs or buboes. Plague is transmitted among animals and people through flea-bites. It can be a severe disease in individuals, with a case-casualty proportion of 30% to 60% for bubonic plague, and if it is untreated, it can be lethal. It is an infectious disease and can trigger widespread epidemic through individual-to-individual contact by means of droplets in air. Antibiotic treatment is effective against plague microorganisms.

Increase in incidence of plague is one of the major factors fueling the global plague therapeutics market. Rise in adoption of companion animals and increase in awareness about plague immunization are expected to drive the global plague therapeutics market. However, strict regulations for vaccine approval is likely to hamper the market during the forecast period.

Based on therapeutic type, the global plague therapeutics market can be bifurcated into vaccine and drugs. The drugs segment is likely to expand at a significant pace during the forecast period because of the wide availability and use of antibiotic drugs for treatment. The vaccine segment can be classified into live attenuated vaccine, recombinant vaccine, and inactivated vaccine. The live attenuated vaccine segment is likely to grow at a rapid pace during the forecast period, as live attenuated vaccines have high antigenic properties which provide a prolonged stimulation to the immune system against plague. In terms of distribution channel, the global plague therapeutics market can be divided into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period, as several types of drugs and vaccines are widely available in hospital pharmacies. Moreover, during pneumonic plague, a patient needs antibiotic within 24 hours to prevent death. Hence, patients prefer hospital pharmacies.

In terms of region, the global plague therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global plague therapeutic market. The region is projected to account for a significant share of the global plague therapeutic market during the forecast period due to increase in adoption of companion animals in households and high prevalence of plague diseases in rural & semi-rural areas especially in Southwest U.S. Europe is next lucrative plague therapeutic market for plague therapeutics. Availability of different types of plague vaccines, rise in awareness about plague diseases in countries such as China, India, Mongolia, and Vietnam makes Asia Pacific a promising plague therapeutic market for plague therapeutics during the forecast period. Advancements in drug delivery system, rise in awareness about plague immunization, and high prevalence of plague disease in sub-Saharan Africa are likely to augment the plague therapeutics market in Middle East & Africa during the forecast period.

Key players operating in the global plague therapeutics market are iBio, Inc., DynPort Vaccine Company LLC, Bayer Healthcare, Pfizer, Inc., and AstraZeneca, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients